≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Toxic effect of organic solvents

Endpoint Browser

ST19_TOXIC_EFFECT_ORGANIC_SOLVE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — T52
  • Cause of death: ICD-10 — T52

2 out of 7 registries used, show all original rules.

154

4. Check minimum number of events

None

154

5. Include endpoints

None

154

6. Filter based on genotype QC (FinnGen only)

127

Control definitions (FinnGen only)

Control exclude
ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T5[1-9]|T6[0-5]
Name in latin
Effectus toxicus solventium organicorum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 127 47 80
Unadjusted period prevalence (%) 0.03 0.02 0.04
Median age at first event (years) 37.06 24.60 44.38

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
148
Matched controls
1480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
42.1
96.8
65
27
T52.9
ICD-10 Finland
Toxic effect: Organic solvent, unspecified
+∞
94.1
80
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
31.5
85.3
64
35
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
11.2
40.7
53
70
Z72.2
ICD-10 Finland
Drug use
+∞
28.0
26
*
WX892
NOMESCO Finland
Monitored bed care
9.6
26.7
36
48
T52.8
ICD-10 Finland
Toxic effect: Other organic solvents
+∞
24.7
23
*
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
33.7
23.4
30
11
N07BB01
ATC
disulfiram; oral
9.4
22.6
30
39
P19
ICPC
Drug abuse
71.0
21.6
24
*
T52.3
ICD-10 Finland
Toxic effect: Glycols
+∞
21.4
20
*
T52.0
ICD-10 Finland
Toxic effect: Petroleum products
+∞
21.4
20
*
X46
ICD-10 Finland
Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
242.8
21.2
21
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.4
19.0
48
121
N06AB04
ATC
citalopram; systemic
5.1
18.3
51
139
N05AH04
ATC
quetiapine; oral
4.6
18.3
63
204
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
+∞
18.1
17
*
N05AH03
ATC
olanzapine; systemic
6.0
17.7
37
78
TKC20
NOMESCO Finland
Catheterisation of bladder
8.1
17.6
26
38
Z2446
NOMESCO Finland
Social worker
7.1
16.2
27
45
N05BA01
ATC
diazepam; systemic, rectal
5.1
16.1
41
103
X57
ICD-10 Finland
Unspecified privation
14.7
15.6
26
21
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.7
15.4
45
126
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.3
14.8
28
53
N05BA12
ATC
alprazolam; oral
5.5
14.6
33
74
N03AE01
ATC
clonazepam; systemic
7.2
14.2
23
37
B18.2
ICD-10 Finland
Chronic viral hepatitis C
20.8
13.8
20
11
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
153.5
13.7
14
*
P15
ICPC
Chronic alcohol abuse
11.8
13.6
25
25
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
31.7
13.3
17
6
N05CD07
ATC
temazepam; oral
5.6
13.2
28
59
F10.20
ICD-10 Finland
Alcohol dependence currently independent
17.6
13.0
20
13
N05BA04
ATC
oxazepam; oral
3.7
12.9
60
232
N06AX11
ATC
mirtazapine; oral
3.5
12.8
73
321
T51.0
ICD-10 Finland
Toxic effect: Ethanol
+∞
12.7
12
*
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
+∞
12.7
12
*
X59
ICD-10 Finland
Exposure to unspecified factor
3.7
12.3
53
194
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
51.2
12.1
14
*
N05AX08
ATC
risperidone; systemic
4.8
11.9
31
78
WX730
NOMESCO Finland
Conventional respirator
25.4
11.8
16
7
P29
ICPC
Psychological sympt/compl other
4.5
11.6
33
89
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.0
11.5
22
42
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
12.6
11.5
20
18
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.5
11.4
24
50
N03AG01
ATC
valproic acid; systemic, rectal
5.0
11.3
27
63
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.1
11.2
21
39
Z2221
NOMESCO Finland
Medical doctor
3.4
11.2
56
224
XF400
NOMESCO Finland
ECG with 12 standard connections
4.1
10.8
35
104
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
64.8
10.8
12
*
N05AA02
ATC
levomepromazine; systemic
8.6
10.7
23
31
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
35.3
10.5
13
*
N05BA02
ATC
chlordiazepoxide; systemic
18.4
10.1
15
9
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
28.2
10.0
13
5
T74.1
ICD-10 Finland
Physical abuse
11.2
9.8
18
18
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
106.6
9.5
10
*
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
23.6
9.5
13
6
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.2
9.5
29
82
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
+∞
9.5
9
*
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
+∞
9.5
9
*
F10.25
ICD-10 Finland
Alcohol dependence continuous use
12.6
9.3
16
14
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
7.7
9.2
21
31
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
39.3
9.2
11
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
39.3
9.2
11
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.4
9.1
25
65
P16
ICPC
Acute alcohol abuse
13.7
9.1
15
12
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
25.9
9.1
12
5
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
8.5
9.0
19
25
A46
ICD-10 Finland
Erysipelas
3.7
8.9
33
107
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
53.2
8.8
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.0
8.7
20
45
Z3231
NOMESCO Finland
Registered nurse
2.9
8.5
53
236
S01.0
ICD-10 Finland
Open wound of scalp
4.3
8.5
24
64
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
4.1
8.3
25
70
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
18.5
8.2
12
7
N05CF02
ATC
zolpidem; oral
3.3
7.9
34
121
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.0
7.9
18
40
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
7.8
60
296
N06AB03
ATC
fluoxetine; oral
3.6
7.7
28
89
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.8
7.7
51
233
N06AB06
ATC
sertraline; oral
3.4
7.6
32
112
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
7.5
29
96
ZY000
NOMESCO Finland
Hospital inpatient
14.4
7.5
12
9
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
84.1
7.5
8
*
N05CF01
ATC
zopiclone; oral
2.7
7.4
54
258
Z2445
NOMESCO Finland
Psychologist
4.9
7.4
17
38
ZXD05
NOMESCO Finland
Urgent procedure
2.7
7.4
57
281
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
7.2
7.4
17
26
P99
ICPC
Psychological disorders other
7.2
7.4
17
26
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
+∞
7.3
7
*
N05AX12
ATC
aripiprazole; systemic
4.1
7.3
22
61
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
31.7
7.2
9
*
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
31.7
7.2
9
*
F10.24
ICD-10 Finland
Alcohol depence active use
9.5
7.2
14
16
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.5
7.2
18
31
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.8
7.2
17
39
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
14.7
7.0
11
8
N06AX16
ATC
venlafaxine; oral
3.1
7.0
34
130
AA1AD
NOMESCO Finland
CT of head and brain
2.7
7.0
49
229
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
17.7
6.8
10
6
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
42.0
6.8
8
*
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
8.0
6.6
14
19
IFC99
NOMESCO Finland
Other biological psychiatric intervention
72.9
6.5
7
*
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
72.9
6.5
7
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.2
6.5
18
47
ZY010
NOMESCO Finland
Hospital outpatient
4.0
6.4
19
52
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
28.0
6.3
8
*
T52.2
ICD-10 Finland
Toxic effect: Homologues of benzene
+∞
6.3
6
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
8.3
6.3
13
17
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.3
6.3
13
17
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.5
6.3
16
39
N06AB10
ATC
escitalopram; oral
2.6
6.2
47
226
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.9
6.2
34
139
JN4BD
NOMESCO Finland
Extensive body CT
3.9
6.1
19
54
N06BA04
ATC
methylphenidate; oral
4.4
6.1
16
40
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
7.8
6.1
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
36
51
9.01
25.41
4.5
1.9
—
—
—
0
0
38
79
6.13
18.52
7.4
1.8
—
—
—
0
0
41
95
5.59
17.74
4.4
1.7
—
—
—
0
0
24
11
25.71
17.52
2.2
3.1
—
—
—
0
0
41
113
4.64
14.23
6.5
1.6
—
—
—
0
0
42
120
4.49
13.90
6.5
1.6
—
—
—
0
0
42
121
4.45
13.74
6.4
1.6
—
—
—
0
0
41
119
4.38
13.25
6.5
1.6
—
—
—
0
0
40
120
4.20
12.31
6.3
1.6
—
—
—
0
0
37
109
4.19
11.62
13.3
11.6
—
—
—
0
0
70
321
3.24
11.14
8.8
4.5
—
—
—
0
0
34
109
3.75
9.37
6.7
4.5
1.87
1.48
mmol/l
0.21
26
91
34
114
3.57
8.74
6.7
4.7
7.35
7.38
ph
0.76
19
74
30
93
3.79
8.64
2.3
1.5
0.23
0.28
mg/l
0.22
21
41
8
0
+∞
8.41
10.1
0.0
—
—
mmol/l
—
0
0
8
0
+∞
8.41
10.1
0.0
—
—
mmol/l
—
0
0
46
200
2.89
7.59
3.1
3.4
651.12
380.35
ng/l
0.18
21
146
82
483
2.56
7.32
10.3
7.8
1.20
1.21
mmol/l
1.04
77
449
86
528
2.50
6.89
10.4
8.4
1.20
1.21
mmol/l
0.60
78
466
25
82
3.47
6.56
10.2
10.2
22.38
24.74
mmol/l
2.15
25
82
37
162
2.71
5.90
1.6
1.7
—
—
—
0
0
93
626
2.31
5.61
8.6
6.9
9.10
11.80
umol/l
3.66
85
601
102
720
2.34
5.41
8.9
6.0
6.51
6.62
mmol/l
0.14
97
675
46
244
2.28
4.79
1.8
1.7
—
—
—
0
0
52
292
2.20
4.71
2.3
2.2
2.67
2.91
mg/l
0.39
47
253
59
349
2.15
4.69
10.9
6.7
—
—
—
0
0
67
417
2.11
4.66
2.8
2.2
—
—
—
0
0
54
310
2.17
4.62
3.8
3.6
7.39
7.39
ph
0.27
36
213
30
134
2.55
4.53
14.0
13.4
7.39
7.42
ph
0.90
18
76
54
313
2.14
4.49
6.2
3.3
1.01
1.02
kg/l
3.77
45
207
30
136
2.51
4.39
13.7
13.2
12.18
12.25
kpa
0.03
30
130
30
136
2.51
4.39
14.0
13.2
5.47
5.07
kpa
2.09
30
128
27
120
2.53
4.11
14.3
14.7
96.57
95.39
%
0.66
27
115
10
18
5.87
4.05
2.0
1.7
—
—
—
0
0
38
199
2.22
4.02
3.4
4.1
0.81
0.83
mmol/l
0.41
38
189
34
172
2.27
3.89
2.4
2.3
—
—
—
0
0
63
409
1.94
3.70
3.8
2.8
55.93
64.84
u/l
0.38
58
382
11
25
4.67
3.70
1.4
1.2
453.45
614.40
mg/l
0.51
11
25
31
154
2.28
3.69
1.6
1.6
958.46
1166.32
nmol/l
0.53
24
121
115
923
2.10
3.52
11.7
8.0
77.95
77.63
u/l
0.04
110
874
10
22
4.79
3.50
1.2
1.3
3.41
3.80
mmol/l
—
10
22
34
180
2.15
3.47
13.4
8.3
103.62
104.61
mmol/l
0.46
34
180
30
151
2.24
3.46
1.6
3.7
3.73
6.00
umol/l
2.04
22
131
16
62
2.77
3.16
5.6
3.1
0.54
0.65
%
0.81
16
62
63
426
1.83
3.16
4.6
3.6
25.40
30.33
ng/l
0.27
39
265
67
465
1.81
3.07
2.5
1.9
91.55
93.94
pmol/l
0.19
44
271
23
109
2.31
3.04
5.4
7.1
6.33
8.30
mmol/l
1.22
23
104
33
182
2.05
3.01
3.2
2.9
3.72
2.51
e6/l
0.23
13
101
61
416
1.79
2.93
7.1
6.3
—
—
—
0
0
41
247
1.91
2.91
1.8
2.7
538.74
569.40
mosm/kgh2o
0.35
35
220
57
384
1.79
2.84
3.9
2.4
—
—
—
0
0
12
40
3.17
2.77
1.8
1.9
155.08
223.80
ug/l
0.33
12
40
10
29
3.62
2.75
4.7
2.4
7.41
7.41
ph
—
10
29
58
398
1.75
2.68
6.1
3.0
8.39
8.99
mmol/l
0.37
53
349
42
262
1.84
2.67
1.6
1.9
0.70
1.31
mg/l
1.57
32
197
10
30
3.50
2.66
1.4
1.1
—
—
—
0
0
19
88
2.33
2.64
2.2
2.7
61.86
72.35
e9/l
—
7
69
64
454
1.72
2.62
3.6
3.7
35.17
89.71
e6/l
0.94
42
332
14
56
2.66
2.62
1.6
1.2
—
—
—
0
0
27
146
2.04
2.59
1.6
1.7
—
—
—
0
0
10
31
3.38
2.57
1.1
1.1
—
—
—
0
0
5
7
7.34
2.57
1.4
2.3
—
—
—
0
0
50
334
1.75
2.52
3.0
2.8
0.35
0.34
e6/l
0.02
32
262
7
16
4.54
2.50
17.6
11.5
0.62
0.57
mmol/l
—
7
16
8
21
3.96
2.50
3.4
2.0
17.53
16.97
%
—
8
21
49
326
1.75
2.50
2.0
1.8
—
—
—
0
0
112
935
1.81
2.48
4.8
3.8
14.04
14.64
pmol/l
2.10
103
858
6
12
5.16
2.42
1.2
1.2
—
—
—
0
0
75
566
1.66
2.38
4.8
3.0
6.43
6.13
ph
1.30
51
318
56
394
1.68
2.31
3.0
3.0
9.93
223.83
e6/l
0.77
39
319
7
18
4.03
2.28
3.6
2.0
1.70
1.95
mmol/l
—
7
18
5
9
5.70
2.23
1.0
1.4
2.44
2.07
mmol/l
—
5
9
6
14
4.42
2.17
2.7
2.0
11.70
12.34
%
—
6
14
9
31
3.02
2.11
1.6
3.3
9.80
8.68
kpa
—
9
31
5
10
5.13
2.08
1.2
1.0
—
—
—
0
0
15
71
2.24
2.00
1.3
1.4
—
39.95
—
0
8
6
17
3.63
1.85
1.3
1.7
16.50
51.46
ng/l
—
6
17
14
67
2.20
1.82
2.1
4.6
4.78
4.66
pmol/l
0.16
14
58
17
89
2.03
1.78
2.3
3.6
7.42
7.41
ph
0.02
12
72
10
206
0.45
1.69
1.6
1.4
—
—
—
0
0
5
14
3.66
1.63
4.0
3.1
—
—
—
0
0
41
551
0.65
1.56
2.5
2.7
—
—
—
0
0
6
21
2.93
1.52
6.2
2.5
9.75
9.20
kpa
—
6
21
6
21
2.93
1.52
6.2
2.5
5.12
4.91
kpa
—
6
21
15
80
1.97
1.51
2.1
2.4
—
18.80
—
0
9
17
96
1.87
1.46
3.2
3.8
7.32
7.32
ph
0.03
11
72
89
751
1.46
1.44
17.3
10.5
4.57
4.05
e9/l
0.83
77
665
62
489
1.46
1.42
13.2
11.1
1.19
1.18
inr
0.02
49
398
6
23
2.67
1.38
2.8
1.6
—
—
—
0
0
125
1136
1.65
1.38
6.3
4.6
1.79
1.81
mu/l
0.07
115
1056
42
308
1.51
1.37
2.6
2.6
—
—
—
0
0
43
317
1.50
1.37
3.4
3.3
—
0.40
—
0
5
75
618
1.43
1.35
8.6
6.7
2.48
2.71
%
0.60
69
596
22
139
1.68
1.32
1.5
1.6
—
—
—
0
0
75
620
1.43
1.31
8.6
6.9
8.59
8.76
%
0.24
69
599
10
48
2.16
1.31
2.7
1.3
—
—
—
0
0
82
690
1.42
1.30
11.0
7.3
0.19
0.19
e9/l
0.13
72
628
74
616
1.40
1.22
8.7
6.9
0.64
0.64
%
0.01
67
591
70
578
1.40
1.21
12.2
10.9
0.00
0.00
e9/l
0.52
53
467
79
666
1.40
1.21
9.6
6.8
0.64
0.57
e9/l
0.98
69
590
0
33
0.00
1.17
0.0
3.4
—
—
—
0
0
12
65
1.92
1.17
2.8
3.9
—
—
—
0
0
79
670
1.38
1.14
9.7
6.8
0.04
0.04
e9/l
1.04
68
593
22
146
1.60
1.11
1.1
1.3
—
—
—
0
0
127
1178
1.55
1.05
5.5
4.1
6.27
5.84
mmol/l
0.66
112
1094
21
140
1.58
1.04
1.0
1.3
—
—
—
0
0
11
61
1.87
1.01
2.9
2.2
—
—
—
0
0
15
231
0.61
1.01
1.5
1.6
—
—
—
0
0
0
29
0.00
0.99
0.0
2.8
—
1.44
—
0
29
133
1251
1.62
0.97
28.2
14.0
31.22
24.85
mg/l
0.92
112
1011
8
45
1.82
0.86
1.5
2.1
26.07
23.41
mmol/l
—
8
45
12
74
1.68
0.81
8.9
13.9
26.65
24.09
mmol/l
1.29
12
69
37
293
1.35
0.79
2.7
2.7
342.61
350.05
umol/l
0.13
31
264
23
304
0.71
0.74
3.1
3.1
0.56
0.69
ug/l
0.76
17
181
5
25
2.03
0.73
1.0
1.8
94.34
91.03
%
—
5
25
78
692
1.27
0.71
9.9
6.8
1.96
1.95
e9/l
0.04
68
634
0
22
0.00
0.60
0.0
2.8
—
7.04
—
0
22
41
344
1.27
0.58
3.6
3.4
—
—
—
0
0
51
443
1.23
0.53
2.0
2.0
—
—
—
0
0
9
64
1.43
0.52
1.7
1.4
—
—
—
0
0
10
144
0.67
0.52
1.2
1.9
—
—
—
0
0
11
76
1.48
0.49
7.4
10.7
—
—
—
0
0
27
322
0.80
0.43
5.4
5.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
34.55
—
0
16
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
13
98
1.36
0.39
3.0
6.0
0.33
0.50
%
—
6
32
6
41
1.48
0.36
17.8
11.9
—
—
—
0
0
11
82
1.37
0.35
1.9
3.2
—
—
—
0
0
6
86
0.69
0.34
1.2
1.9
1.24
1.26
g/l
—
6
81
7
54
1.31
0.31
1.0
1.1
—
—
—
0
0
14
171
0.80
0.28
1.2
1.5
—
457.93
—
0
29
8
66
1.22
0.27
4.8
5.5
36.99
36.97
°c
—
8
66
74
696
1.13
0.26
3.9
3.4
0.00
0.00
estimate
-0.00
14
149
5
37
1.36
0.24
1.6
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
80.09
—
0
11
0
11
0.00
0.21
0.0
6.5
—
9.27
—
0
11
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
3.3
—
40.91
—
0
11
0
10
0.00
0.21
0.0
1.4
—
12.80
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
42
387
1.12
0.20
4.1
3.5
0.00
0.01
estimate
0.50
13
139
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
49
1.23
0.20
1.8
2.1
—
—
—
0
0
28
310
0.88
0.20
1.5
1.5
2.34
2.50
g/l
0.29
20
203
13
109
1.21
0.19
2.9
6.1
0.50
0.87
%
—
6
39
5
66
0.75
0.17
1.2
2.0
—
—
—
0
0
23
206
1.14
0.17
1.3
1.3
26.07
35.74
iu/ml
—
8
51
12
141
0.84
0.17
2.2
1.8
3.84
3.54
mmol/l
—
7
105
12
101
1.20
0.17
3.5
1.9
6.60
6.10
ph
—
5
63
12
102
1.19
0.15
3.1
6.4
0.20
0.13
%
—
5
32
129
1310
0.88
0.14
21.3
12.0
—
—
—
0
0
72
692
1.08
0.14
3.8
3.4
0.00
0.00
estimate
-0.00
15
147
12
103
1.18
0.14
2.7
6.8
0.00
0.32
%
—
5
28
31
332
0.92
0.12
3.3
4.0
4.76
11.92
mg/mmol
0.91
18
228
58
556
1.07
0.12
4.6
2.9
—
—
estimate
—
0
0
121
1228
0.92
0.10
5.0
4.4
4.69
4.60
mmol/l
0.44
114
1163
12
135
0.88
0.10
1.8
1.5
—
—
—
0
0
55
529
1.06
0.10
3.7
3.3
0.00
0.03
estimate
0.68
13
125
122
1237
0.92
0.09
5.5
4.8
2.88
2.76
mmol/l
0.65
112
1171
121
1226
0.93
0.08
4.7
4.3
1.34
1.37
mmol/l
0.33
113
1159
10
88
1.15
0.08
1.3
1.4
20.74
109.21
u/ml
—
5
35
6
74
0.80
0.08
1.0
1.2
—
—
—
0
0
72
703
1.05
0.07
4.0
3.5
0.00
0.00
estimate
-0.00
13
137
33
345
0.94
0.07
1.5
1.4
0.84
1.22
u/ml
—
10
103
27
256
1.07
0.07
2.1
2.0
—
—
—
0
0
39
400
0.97
0.03
1.6
1.5
—
—
—
0
0
37
379
0.97
0.02
2.7
2.6
—
0.00
—
0
8
11
104
1.06
0.01
3.5
3.7
—
—
—
0
0
50
494
1.02
0.00
2.1
1.9
1.78
1.46
mmol/l
1.07
45
425
115
1151
1.00
0.00
4.1
3.8
1.50
1.31
mmol/l
1.25
108
1085
39
387
1.01
0.00
2.9
2.9
0.00
0.00
estimate
-0.00
12
117
32
325
0.98
0.00
2.7
3.3
49.73
71.93
mg/l
0.23
19
228
114
1142
0.99
0.00
5.5
5.3
38.05
38.43
mmol/mol
0.18
107
1085
13
128
1.02
0.00
1.2
1.2
—
—
—
0
0
8
84
0.95
-0.00
2.3
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.7
—
4.04
—
0
9
0
6
0.00
-0.00
0.0
1.7
—
1.33
—
0
6
8
79
1.01
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
0.53
—
0
9
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
13.84
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
28.83
—
0
6
7
75
0.93
-0.00
1.3
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
0.45
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
11.23
—
0
6
0
5
0.00
-0.00
0.0
2.0
—
58.80
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
11.74
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.00
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
21.71
—
0
7
0
5
0.00
-0.00
0.0
64.0
—
89.80
—
0
5
0
9
0.00
-0.00
0.0
2.7
—
106.11
—
0
9
16
160
1.00
-0.00
1.2
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
8.40
—
0
5
0
9
0.00
-0.00
0.0
2.7
—
1.18
—
0
9
0
6
0.00
-0.00
0.0
1.7
—
6.53
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
9.07
—
0
6
0
8
0.00
-0.00
0.0
1.6
—
1743.13
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
82
0.97
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_TOXIC_EFFECT_ORGANIC_SOLVE – Toxic effect of organic solvents

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).